Associations between site practices and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry

Please find below a podcast of Dr Joao de Andrade and Dr Tejaswini Kulkarni discussing data from the IPF-PRO Registry on the resources and practices of the centers in the registry and how this might relate to patient outcomes.

New Mic
Header - Navigation Icon

The IPF-PRO/ILD-PRO™ Registry is funded by Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and co-ordinated by the Duke Clinical Research
Institute (DCRI). The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). The authors did not receive payment for the development of this podcast or the article on which it was based. Writing support for the manuscript was provided by Julie Fleming and Wendy Morris of Fleishman-Hillard, London, UK, which was contracted and funded by BIPI. Boehringer Ingelheim (BI) was given the opportunity to review the article and podcast for medical and scientific accuracy as well as intellectual property considerations.